»úеѧϰËã·¨ÊÇÈÃÅÌËã»ú´ÓÊý¾ÝÖÐ×Ô¶¯Ñ§Ï°¼ÍÂÉ£¬²¢»ùÓÚÕâЩ¼ÍÂɾÙÐÐÕ¹Íû»ò¾öÒéµÄÊýѧģ×ÓºÍÒªÁì¡£¿ËÈÕ£¬333ÌåÓý¹ÙÍøÑ¬È¾¼²²¡Õï¶ÏÖÐÐÄÍŽáÕã½´óѧҽѧԺÁ¥ÊôÉÛÒÝ·òҽԺѬȾ¿Æ£¬ÏµÍ³Ì½ÌÖÁË»úеѧϰËã·¨ÔÚ½áºË·ÖÖ¦¸Ë¾úÄÍÒ©ÐÔÕ¹Íû¼°Òªº¦Í»±äλµã£¨SNPs£©ÅжÏÖеÄÓ¦ÓüÛÖµ¡£
Ñо¿Í¨¹ýÕûºÏÈ«»ùÒò×é²âÐò£¨WGS£©Êý¾ÝÓëÒ©ÃôÊÔÑéЧ¹û£¨AST£©£¬¹¹½¨ÁË»ùÓÚ12ÖÖ»úеѧϰËã·¨¶Ô18ÖÖ¿¹½áºËÒ©ÎïÄÍÒ©ÐԵľ«×¼Õ¹ÍûÄ£×Ó£¬Í¨¹ýSHAPÖµ£¨SHapley Additive exPlanations£©ÆÊÎöÕ¹ÏÖÁËÈ´ºË·ÖÖ¦¸Ë¾úSNPsÍ»±äÔÚÌØ¶¨¿¹½áºËÒ©ÎïµÄÄÍÒ©ÐÔÕ¹ÍûÖеÄТ˳ֵ£¬²¢ÔÚÁ½¸ö×ÔÁ¦Êý¾Ý¼¯ÖÐÑéÖ¤ÁËÄ£×ÓµÄÕ¹ÍûЧ¹û¡£¸ÃÑо¿Ð§¹ûÊÕ¼ÓÚ¹ú¼ÊÆÚ¿¯¡¶BMC Genomic Data¡·£¨IF: 2.5£©¡£
ÂÛÎÄÐû²¼½ØÍ¼
¸ÃÑо¿Ð§¹ûÅú×¢£¬»ùÓÚ15¸öÖ÷Òªµ¥ºËÜÕËá¶à̬ÐÔλµã£¨SNPs£©Ê±£¬ÌݶÈÌáÉý·ÖÀàÆ÷£¨GBC£©Ä£×ÓÔÚ׼ȷչÍû¿¹½áºËÒ©ÎïµÄÄÍÒ©ÐÔ·½ÃæÌåÏÖ×î¼Ñ£¨¶ÔÀû¸£Æ½¡¢ÒìÑÌë¡¢ßÁàºõ£°·ºÍÒÒ°·¶¡´¼ËÄÖÖÒ»ÏßÒ©ÎïÄÍÒ©ÐÔÕ¹ÍûµÄ׼ȷÂÊ»®·ÖÊÇ97.28%¡¢96.06%¡¢94.19%ºÍ92.81%£©¡£Î»ÓÚ½áºË·ÖÖ¦¸Ë¾ú»ùÒò×é761155£¨rpoB_p.Ser450£©ºÍ2155168£¨katG_p.Ser315£©Î»ÖõÄSNPs¶ÔÒ©ÎïÄÍÒ©ÐÔµÄÕ¹ÍûТ˳ֵÅÅÃû¿¿Ç°£¬ÕâЩλµã±¬·¢Í»±äʱ½áºË·ÖÖ¦¸Ë¾úÇãÏòÓÚ¶ÔÀû¸£Æ½ºÍÒìÑÌ뱬·¢ÄÍÒ©¡£
±ðµÄ£¬ÔÚÓ¡¶ÈºÍÒÔÉ«ÁеÄ×ÔÁ¦½áºË·ÖÖ¦¸Ë¾úÊý¾Ý¼¯ÖУ¬×î¼ÑÄ£×ÓGBC¶ÔÀû¸£Æ½ºÍÒìÑÌëµÄÄÍÒ©ÐÔÕ¹ÍûÒ²¾ßÓкܺõij°ôÐÔ¡£¸ÃÑо¿½«»úеѧϰҪÁìÕûºÏµ½¿¹½áºËÒ©ÎïÄÍÒ©ÐÔÕ¹ÍûºÍÄÍÒ©ÐÔÏà¹ØSNPsµÄÅжÏÑо¿ÖУ¬Ì½Ë÷ÁËÖ÷ÒªSNPs¶ÔÄ£×Ó¾öÒéµÄТ˳ˮƽ£¬Ê¹»úеѧϰËã·¨µÄÀú³ÌÔ½·¢Í¸Ã÷¡¢¿ÉÚ¹ÊÍ¡£Ñо¿Ð§¹ûµÄ½ÒÏþ£¬Îª333ÌåÓý¹ÙÍø»ùÓÚAIÔÚ²¡ÔѬȾÁÙ´²Ò©ÎïÄÍÒ©ÐÔÕ¹ÍûÁìÓòµÄÓ¦Óã¬ÌṩÁËÔúʵµÄÀíÂÛÒÀ¾Ý¡¢ÊÖÒÕÖ§³ÖºÍÁÙ´²×ª»¯µÄ̽Ë÷Æ«Ïò¡£
Ñо¿Åä¾°
½áºË·ÖÖ¦¸Ë¾ú£¨MTB£©Ñ¬È¾ÈËÀàÒýÆðµÄ½áºË²¡£¬ÖÁ½ñÈÔÊÇÈ«Çò¿µ½¡µÄÖØ´óÍþв¡£¾Ýͳ¼Æ£¬2021ÄêÈ«ÇòÐÂÔö½áºË²¡²¡Àý´ï1060Íò£¬140ÍòÈËËÀÓÚÓë½áºË²¡Ïà¹ØµÄ¼²²¡[1]£¬ÆäÖÐÀû¸£Æ½ÄÍÒ©£¨RR£©»òÄͶàÒ©£¨MDR£©½áºË²¡¸üÊÇÈÃÖÎÁÆÑ©ÉϼÓ˪£¬³õÖλ¼ÕßÖÐÄͶàÒ©/Àû¸£Æ½ÄÍÒ©ÂÊΪ3.6%¡¢¸´Öλ¼ÕßÖÐÄÍÒ©ÂÊΪ18%[1]¡£×÷ΪȫÇòµÚ¶þ´óÄͶàÒ©½áºË²¡±¨¸æ¹ú£¬ÖйúµÄ·À¿ØÑ¹Á¦ÓÈΪͻ³ö[2]¡£
¹Å°å¼ì²âÄÍÒ©ÐÔµÄÒªÁìÒÀÀµÓÚ»ºÂýµÄ½áºË·ÖÖ¦¸Ë¾ú×÷Óý£¬¶¯éüÐèÒªÊýÖÜ¡£×ÝÈ»ÊÇXpertÖзÖ×ÓÕï¶ÏÊÖÒÕ£¬Ò²Ö»ÄÜÕë¶ÔÓÐÏ޵ĻùÒòλµã£¬ÄÑÒÔÁýÕÖ¸ü¶à¿¹ÉúËØµÄÄÍÒ©ÐÔ[3]¡£È«»ùÒò×é²âÐò£¨WGS£©ËäÄܲ¶»ñ½áºË·ÖÖ¦¸Ë¾úµÄ»ùÒòÍ»±ä£¬µ«ÏÖÔÚ¶ÔÒÒ°·¶¡´¼¡¢ßÁàºõ£°·µÈÒ©ÎïµÄÄÍÒ©ÐÔÕ¹Íû׼ȷÂʽϵͣ¬¶Ô¶þÏßÒ©ÎïµÄÕ¹ÍûЧ¹û¸üÊÇÀǼ®²»Æë[4,5]¡£
ÔÚWGSÊý¾ÝÉÏÓ¦Óûúеѧϰ£¬ÎªÕ¹ÏÖ½áºË·ÖÖ¦¸Ë¾úÄÍÒ©ÐԵĻùÒò×é»úÖÆÌṩÁËÖØ´óµÄDZÁ¦¡£±¾Ñо¿ÍŶӽ«WGS»ùÒòÊý¾ÝÓë18ÖÖ¿¹½áºËÒ©ÎïµÄÒ©ÃôÊÔÑéЧ¹ûÍŽᣬ¹¹½¨ÁËÒ»Ì׸ßЧµÄ»úеѧϰչÍû¿ò¼Ü¡£²î±ðÓڹŰåÒªÁì½öÒÀÀµÒÑ֪ͻ±äλµãºÍÌØ¶¨µÄ¿¹½áºËÒ©ÎÕâÌ׿ò¼ÜÄÜͨ¹ý»úеѧϰËã·¨£¬ÔÚÈ«»ùÒò×éˮƽÉÏÖÜÈ«µØÍÚ¾òSNPsÓëÄÍÒ©ÐԵĹØÁª£¬¸üÖ÷ÒªµÄÊÇ£¬Ñо¿²»µ«×·Çó¾«×¼Õ¹Íû£¬¸ü×¢ÖØÕ¹ÍûÀú³ÌµÄ͸Ã÷¿ÉÚ¹ÊÍ¡£¸ÃÑо¿Ê¹ÓõÄÔ´´úÂëºÍÊý¾Ý¼¯ÒÑÔÚGitHub¹ûÕæ£¨https://github.com/microbial123/MTB-AMR£©£¬ÎªÈ«ÇòÑо¿ÕßÌṩÁ˹²Ïí×ÊÔ´¡£
Ñо¿ÒªÁì
ͼ1. Ñо¿Á÷³Ìͼ
¸ÃÑо¿Ê¹ÓÃÁË5739Öê½áºË·ÖÖ¦¸Ë¾úµÄWGSÊý¾Ý¼¯ºÍ18ÖÖ¿¹½áºËÒ©ÎïµÄÒ©ÃôÊÔÑéЧ¹û£¬Í¨¹ý¹¹½¨ËùÓÐSNPs¡¢½»¼¯SNPsºÍËæ»ú³éÈ¡µÄSNPsµÄѵÁ·Êý¾Ý¼¯ºÍ²âÊÔÊý¾Ý¼¯£¬»ùÓÚ12ÖÖ²î±ðµÄ»úеѧϰËã·¨£¬¿ª·¢ÁËÒ»¸ö¿¹½áºËÒ©ÎïÄÍÒ©ÐÔÕ¹ÍûºÍÄÍÒ©Ïà¹ØSNPsÅжϵĿò¼Ü¡£È»ºó£¬¸ÃÑо¿½ÏÁ¿ÁËÖÖÖÖ»úеѧϰģ×ÓµÄÐÔÄÜ£¬Ê¹ÓÃSHAP¿ò¼ÜÕ¹ÏÖÁË×î¼ÑËã·¨ÖÐ×ö³ö×îÖÕÄÍÒ©Õ¹Íû¾öÒéµÄÔµ¹ÊÔÓɺͷ½·¨¡£×îºó£¬¸ÃÑо¿»¹»®·ÖÔÚÀ´×ÔÓ¡¶ÈºÍÒÔÉ«ÁеÄ×ÔÁ¦Êý¾Ý¼¯ÖÐÓ¦ÓÃÕâЩģ×Ó£¬¶ÔÀû¸£Æ½ºÍÒìÑÌëµÄÄÍÒ©ÐÔ¾ÙÐÐÑéÖ¤¡£
Ñо¿Ð§¹û
Ñо¿ÍŶӴÁËÒ»¸ö»ùÓÚ12ÖÖ»úеËã·¨Õ¹Íû½áºË·ÖÖ¦¸Ë¾úÊèÉ¢Öê¶Ô18ÖÖ¿¹½áºËÒ©ÄÍÒ©±íÐ͵Ļúеѧϰ¿ò¼Ü£¬ÏÖÓÐÓùûÅú×¢£¬Ã»ÓÐÈκÎÒ»¸öÄ£×ÓÄÜÔÚËùÓÐÇéÐÎ϶¼Ê¼ÖÕÌåÏÖÓÅÒì¡£ÍŶÓͨ¹ý¾«¶È¡¢ÕÙ»ØÂÊ¡¢F1·ÖÊý¡¢auROC¡¢auPRµÈ¶àÏîÖ¸±ê£¬ÏµÍ³µØÆÀ¹ÀÁË12ÖÖ»úеѧϰģ×ÓµÄÄÍÒ©ÐÔÕ¹ÍûÄÜÁ¦£¨Í¼2A£©¡£
Ч¹ûÏÔʾ£¬ÌݶÈÌáÉý·ÖÀàÆ÷£¨GBC£©ÌåÏÖ×îÓÅ£¬ÓÈÆäÔÚÕ¹ÍûÀû¸£Æ½£¨RIF£©ÄÍÒ©ÐÔʱ£¬×¼È·Âʸߴï97.28%¡£¶ÔÒìÑÌë¡¢ßÁàºõ£°·ºÍÒÒ°·¶¡´¼ÈýÖÖÒ»ÏßÒ©ÎïÄÍÒ©ÐÔÕ¹ÍûµÄ׼ȷÂÊ£¬»®·ÖÊÇ96.06%¡¢94.19%ºÍ92.81%¡£×°´üʽ·ÖÀàÆ÷£¨BC£©¡¢×Ô˳ӦÔöÇ¿·ÖÀàÆ÷£¨ABC£©½ôËæØÊºó£¬ÓëGBCÅäºÏõÒÉíǰÈýÃû¡£
Ïà±È֮ϣ¬ÆäËûÒªÁ죬ÈçgNB£¬LogRºÍSVM£¬¾ßÓнϵͻòÏ൱µÄ׼ȷÂÊ£¬¹æÄ£´ÓgNBµÄ74.48%¡¢LogRµÄ96.44%µ½SVMµÄ97.07%¡£ÖµµÃ¹Ø×¢µÄÊÇ£¬¾ÓÉ ¡°½»¼¯Êý¾Ý¼¯¡±ÑéÖ¤£¬Ä£×ÓµÄF1-scoreÏÔÖø¸ßÓÚËæ»úÊý¾Ý¼¯£¬ÇÒ6ÕÛ½»Ö¯ÑéÖ¤µÄÎȹÌÐÔÓÅÓÚ5ÕÛ½»Ö¯ÑéÖ¤£¬Ö¤ÊµÆäЧ¹û¿É¿¿¡¢ÎȽ¡¡£
SHAP½âÂëÄÍÒ©Í»±äλµã£¬Ä£×Ó¾öÒé²»ÔÙ¡°ºÚÏ䡱
¹â×¼»¹²»·ó£¬»úеѧϰģ×ӵġ°¿ÉÚ¹ÊÍÐÔ¡±ÊÇÂ䵨ÁÙ´²µÄÒªº¦¡£Ñо¿ÍŶÓͨ¹ýSHAPÖµÆÊÎö£¬½Ò¿ªÁËGBCÄ£×ӵġ°¾öÒéÂß¼¡±¡£ÔÚÀû¸£Æ½ÄÍÒ©ÐÔÕ¹ÍûÀú³ÌÖУ¬Ç°Èý¸öÒªº¦µÄÄÍÒ©Í»±äλµã»®·ÖÊÇ761155£¨rpoB_p.Ser450£©¡¢2155168£¨katG_p.Ser315£©¡¢761110£¨rpoB_p.Asp435£©£¬ÕâЩλµãµÄÍ»±ä»áÔöÌíÄÍҩΣº¦£¨Í¼2B£©£»ÒìÑÌ루INH£©ÄÍÒ©µÄÒªº¦Í»±äÔò¼¯ÖÐÔÚ2155168£¨katG_p.Ser315£©µÈλµã£¬ÓëÁÙ´²ÒÑÖªÄÍÒ©»úÖÆ¸ß¶ÈÎǺϡ£
SHAP»ã×ÜͼºÍSHAPÁ¦Õù£¬ÏÔʾÁËÖ÷ÒªSNPs¶Ô18ÖÖ²î±ð¿¹½áºËÒ©ÎïÕ¹ÍûЧ¹ûµÄÓ°Ïì¡£ÕâЩ·¢Ã÷Èûúеѧϰģ×Ó´Ó¡°Ö»¸øÐ§¹û¡±Éý¼¶Îª¡°½²ÇåÔµ¹ÊÔÓÉ¡±£¬ÎªÁÙ´²¾«×¼¶¨Î»ÄÍÒ©»ùÒò¡¢Öƶ©¸öÌ廯ÖÎÁƼƻ®ÌṩÁËÀíÂÛÒÀ¾Ý¡£
ͼ2. ÆÀ¹À»úеѧϰËã·¨ÔÚ6ÕÛ½»Ö¯ÑéÖ¤ÖÐÕ¹Íû½áºË·ÖÖ¦¸Ë¾ú¶ÔÀû¸£Æ½ÄÍÒ©ÐÔµÄÐÔÄÜÒÔ¼°Ä£×ӵĿÉÚ¹ÊÍÐÔ
ͨ¹ý¶ÔMTBÄÍÒ©Ïà¹ØSNPsµÄ×¢ÊÍ£¬Ñо¿ÍŶÓÑéÖ¤ÁËÐí¶àÏÈǰ±¨µÀ¹ýµÄ»ùÒò£¬°üÀ¨gyrA¡¢rpoB¡¢embBºÍkatG£¬ÏêÇé¼û±í1ºÍͼS19¡£ÖµµÃ×¢ÖØµÄÊÇ£¬ÔÚ±í1ö¾ÙµÄ15¸öSNPsÖУ¬ÓÐ14¸öÔÚÌìÏÂÎÀÉú×éÖ¯£¨WHO£©Ðû²¼µÄ¡¶½áºË·ÖÖ¦¸Ë¾ú¸´ºÏȺͻ±äĿ¼¼°ÆäÓëÄÍÒ©ÐԵĹØÁª¡·£¨µÚ2°æ£©Öб»Ìá¼°£¬ÆäÖÐ12¸öSNPsÓë¶ÔÖÁÉÙÒ»ÖÖ¿¹ÉúËØµÄÄÍÒ©ÐÔÌØÊâÏà¹Ø£¬±»¹éÀàΪ¡°ÓëÄÍÒ©ÐÔÏà¹Ø¡±£¨Ass-w-R£©»ò¡°ÓëÄÍÒ©ÐÔ¿ÉÄÜÏà¹Ø¡±£¨Ass-w-R-int£©¡£
±í1. MTBÖÐDZÔÚÄÍÒ©ÐÔÏà¹ØµÄSNPsÁбí
ͼS19. MTB¶Ô²î±ð¿¹ÉúËØÄÍÒ©µÄDZÔÚ»ùÒò
Ñо¿ÖеÄ×î¼ÑÄ£×ÓGBC¶ÔÀû¸£Æ½ºÍÒìÑÌëµÄÄÍÒ©ÐÔÕ¹ÍûЧ¹û£¬ÔÚ×ÔÁ¦Êý¾Ý¼¯ÖлñµÃÑéÖ¤
ÔÚÀ´×ÔÓ¡¶È£¨NCBIÏîÄ¿±àºÅ: PRJNA741102£©ºÍÒÔÉ«ÁУ¨NCBI ÏîÄ¿±àºÅ: PRJNA957554£©µÄ×ÔÁ¦Êý¾Ý¼¯ÖУ¬½áºË·ÖÖ¦¸Ë¾ú¶ÔRIF¡¢INH¡¢EMBºÍPZAµÄÄÍÒ©ÂÊºÍÆ×ϵÂþÑÜÈçͼS20¡£Ó¡¶ÈÊý¾Ý¼¯ÖÐÆ×ϵ1Õ¼±È×î¶à£¨50%£©£¬È»¶ø£¬ÔÚÒÔÉ«ÁÐÊý¾Ý¼¯ÖÐÆ×ϵ4×î¶à£¬Õ¼ÊèÉ¢ÖêµÄ41.88%£¨Í¼S20B£©¡£
ÔÚÕâÁ½¸ö×ÔÁ¦ÑéÖ¤Êý¾Ý¼¯ÖУ¬»úеѧϰģ×Ó׼ȷչÍûÁËRIFºÍINHµÄÄÍÒ©±íÐÍ£¬Ä£×ÓµÄÐÔÄÜÈçͼ3Ëùʾ¡£GBCË㷨׼ȷչÍûÁËÁè¼Ý90%µÄMTBÊèÉ¢Öê¶ÔRIFºÍINHµÄÄÍÒ©ÐÔ£¬¿ÉÊÇÄ£×ÓÔÚEMBºÍPZAÖеÄÄÍÒ©ÐÔÕ¹ÍûЧ¹û·×Æç£¬Æ½¾ù׼ȷÂÊ»®·ÖΪ83.73%£¨Ó¡¶È£¬EMB£©¡¢67.42%£¨Ó¡¶È£¬PZA£©¡¢99.05%£¨ÒÔÉ«ÁУ¬EMB£©ºÍ91.14%£¨ÒÔÉ«ÁУ¬PZA£©¡£
ͼS20. Á½¸ö×ÔÁ¦Êý¾Ý¼¯ÖÐMTBÊèÉ¢Öê¶ÔËÄÖÖÒ»ÏßÒ©ÎïµÄÄÍÒ©±íÐÍÕ¼±È
ͼ3. »úеѧϰģ×ÓÔÚ×ÔÁ¦Êý¾Ý¼¯ÖÐÄÍÒ©±íÐÍÕ¹ÍûÖеÄÓ¦ÓÃ
¸ÃÑо¿Ð§¹û²»µ«¸»ºñÁËÈ´ºË·ÖÖ¦¸Ë¾úÄÍÒ©ÐÔÒÅ´«Ñ§»úÖÆµÄÀíÂÛϵͳ£¬¸üΪÄÍÒ©½áºË²¡µÄ¾«×¼ÓÃÒ©ÌṩÁ˼áʵµÄÊý¾ÝÖ§³Ö¡£AI¸³ÄܽáºË²¡ÕïÁƵÄʱ´úÒÑÈ»¿ªÆô¡£ÔÚÕⳡ¶ÔÄÍÒ©¾úµÄ¡°¾«×¼×è»÷¡±ÖУ¬333ÌåÓý¹ÙÍø½«Ò»Á¬Ì½Ë÷¸ÃÊÖÒÕÔÚÁÙ´²³¡¾°µÄ¹æÄ£»¯Ó¦Óã¬ÎªÈ«Çò½áºË²¡·À¿ØÊÂÒµ×¢Èëж¯ÄÜ¡£
²Î¿¼ÎÄÏ×
[1] WHO. Global tuberculosis report 2022. World Health Organization; 2022. https://www.who.int/publications/i/item/9789240061729.
[2] WHO. Global tuberculosis report 2020. World Health Organization; 2020. https://www.who.int/publications/i/item/9789240013131.
[3] Sohn H, Aero AD, Menzies D, Behr M, Schwartzman K, Alvarez GG, Dan A, McIntosh F, Pai M, Denkinger CM. Xpert mtb/rif testing in a low tuberculosis incidence, high-resource setting: limitations in accuracy and clinical impact. Clin Infect Dis. 2014;58:970¨C6.
[4] Sun W, Gui X, Wu Z, Zhang Y, Yan L. Prediction of drug resistance profile of multidrug-resistant mycobacterium tuberculosis (mdr-mtb) isolates from newly diagnosed case by whole genome sequencing (wgs): A study from a high tuberculosis burden country. BMC Infect Dis. 2022;22:499.
[5] Kamolwat P, Nonghanphithak D, Chaiprasert A, Smithtikarn S, Pungrassami P, Faksri K. Diagnostic performance of whole-genome sequencing for identifying drug-resistant Tb in Thailand. Int J Tuberc Lung Dis. 2021;25:754¨C60.